Johnson & Johnson (FRA:JNJ)
€ 138.92 -0.18 (-0.13%) Market Cap: 334.68 Bil Enterprise Value: 341.56 Bil PE Ratio: 9.88 PB Ratio: 5.15 GF Score: 83/100

Johnson & Johnson at Sanford C Bernstein Strategic Decisions Conference Transcript

May 27, 2020 / 02:00PM GMT
Release Date Price: €131.12 (-1.47%)
Lee Michael Hambright
Sanford C. Bernstein & Co., LLC., Research Division - Analyst

All right. Hi, everybody. I'm Lee Hambright, U.S. medical devices analyst at Bernstein. We're thrilled to host Alex Gorsky today from Johnson & Johnson. These are certainly unusual times. I'd like to thank everybody for joining over video conference.

Just a couple of housekeeping items. First, in lieu of question cards in the room, you'll see a pigeon hole link available on the left side of your screen. (Operator Instructions) I'll keep an eye on those questions to make sure we're focusing the conversation on what interests you.

Second, at the end of the session, you'll have access to a very short investor poll through Procensus.

All right. Alex, thanks so much for joining. Before we jump into Q&A, would you please kick us off with some opening remarks.

Alex Gorsky
Johnson & Johnson - Chairman & CEO

Sure, Lee. Well, first of all, thank you very much for having us on today, and I appreciate everybody being able to join through

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot